Why the study?
The study was conducted to evaluate the role of MRI in predicting the efficacy of cardiac resynchronization therapy in patients with left ventricular non-compaction and heart failure.
Does contrast-enhanced cardiac MRI predict the efficacy of cardiac resynchronization therapy in patients with left ventricular non-compaction and heart failure?
Population
26 patients with morphological signs of LVNC cardiomyopathy and HF undergoing CRT
Comparison
Predictive role of pre-procedure contrast-enhanced cardiac MRI
Design
Observational retrospective study
Key result
Pre-procedural cardiac MRI parameters, including myocardial fibrosis and non-compaction severity, predicted the effectiveness of cardiac resynchronization therapy in patients with LVNC and HF.
Authors
Loading...
May aid CRT selection in LVNC-HF via MRI; hypothesis-generating, needs prospective validation.
Observational (n=26)
Does contrast-enhanced cardiac MRI predict the efficacy of cardiac resynchronization therapy in patients with left ventricular non-compaction and heart failure?
Pre-procedural contrast-enhanced cardiac MRI can help predict CRT effectiveness in patients with LVNC and HF by identifying myocardial fibrosis and non-compaction severity.
Мершина et al. (2024) conducted an observational in Left ventricular non-compaction and heart failure (n=26). Contrast-enhanced cardiac MRI was evaluated on Response to CRT (decrease in LV end-diastolic volume and HF functional class). Pre-procedural cardiac MRI parameters, including myocardial fibrosis and non-compaction severity, predicted the effectiveness of cardiac resynchronization therapy in patients with LVNC and HF.